Dysthyroid optic neuropathy: evaluation and management

被引:66
作者
Dolman, P. J. [1 ]
机构
[1] Univ British Columbia, Vancouver Gen Hosp, Dept Ophthalmol & Visual Sci, Vancouver, BC, Canada
关键词
Thyroid eye disease; Graves orbitopathy; Dysthyroid optic neuropathy; Compressive optic neuropathy; Stretch optic neuropathy; Orbital decompression; GRAVES ORBITOPATHY EUGOGO; QUALITY-OF-LIFE; ORBITAL RADIOTHERAPY; EUROPEAN GROUP; TED-QOL; OPHTHALMOPATHY; DISEASE; RISK; QUESTIONNAIRE; DECOMPRESSION;
D O I
10.1007/s40618-020-01361-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Dysthyroid optic neuropathy (DON) is a serious complication of Graves orbitopathy (GO) from optic nerve dysfunction that may result in permanent loss of vision. Purpose This paper reviews the current knowledge of DON, including its pathogenesis and epidemiology, clinical and radiologic features, and management choices and outcomes. Methods Literature review and author retrospective case series. Results Over 90% of DON cases are related to nerve compression by enlarged extraocular muscles (EOM) while the remainder are caused by stretching of the optic nerve without compression. DON's incidence is 5-8% of GO cases. Risk factors include advancing age, male gender, smoking and diabetes mellitus, and these cases should be referred promptly to an ophthalmologist or GO clinic to rule out DON and for ongoing care. Clinical features of DON may include reduction in central and colour vision (unexplained by other ocular disorders), afferent pupil defect and/or optic disc edema. Since most cases are associated with enlarged EOM, restricted motility and soft tissue venous congestion are common. Visual fields and optical coherence tomography (OCT) help confirm the diagnosis while CT or MRI Scans show apical optic nerve compression or proptosis with optic nerve stretch. Standard therapy includes iv/oral corticosteroids (CS) with partial response in most cases, but often relapse with tapering. Radiotherapy may delay or avoid surgery and may prevent the onset of DON when combined with CS in high-risk individuals. The benefits of newer biologic targeted therapy are not clear. Orbital decompression surgery often has positive outcomes, even in cases of severe vision loss or delayed surgery. The most common surgical complication is worsening strabismus, which may worsen visual function and quality of life. In rare cases, permanent vision loss from DON may occur despite full therapy. Conclusions Although DON may cause vision loss, most cases are reversible if recognized and managed in a timely manner.
引用
收藏
页码:421 / 429
页数:9
相关论文
共 50 条
  • [31] Dysthyroid optic neuropathy: emerging treatment strategies
    M. Pelewicz-Sowa
    P. Miśkiewicz
    Journal of Endocrinological Investigation, 2023, 46 : 1305 - 1316
  • [32] Selective Endoscopic Decompression of the Orbital Apex for Dysthyroid Optic Neuropathy
    Chu, Eugene A.
    Miller, Neil R.
    Lane, Andrew P.
    LARYNGOSCOPE, 2009, 119 (06) : 1236 - 1240
  • [33] A British Ophthalmological Surveillance Unit (BOSU) study into dysthyroid optic neuropathy in the United Kingdom
    Wong, Yun
    Dickinson, Jane
    Perros, Petros
    Dayan, Colin
    Veeramani, Pratibha
    Morris, Daniel
    Foot, Barny
    Clarke, Lucy
    EYE, 2018, 32 (10) : 1555 - 1562
  • [34] Predicting dysthyroid optic neuropathy using computed tomography volumetric analyses of orbital structures
    Pieroni Goncalves, Allan C.
    Silva, Lucas Nunes
    Gebrim, Eloisa M. M. S.
    Matayoshi, Suzana
    Ribeiro Monteiro, Mario Luiz
    CLINICS, 2012, 67 (08) : 891 - 896
  • [35] Predictive parameters on CT scan for dysthyroid optic neuropathy
    Yu, Bo
    Gong, Can
    Ji, Yuan-Fei
    Xia, Yu
    Tu, Yun-Hai
    Wu, Wen-Can
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2020, 13 (08) : 1266 - 1271
  • [36] Risk prediction of dysthyroid optic neuropathy based on CT imaging features combined the bony orbit with the soft tissue structures
    Cheng, Shengnan
    Ming, Yangcan
    Hu, Mang
    Zhang, Yan
    Jiang, Fagang
    Wang, Xinghua
    Xiao, Zefeng
    FRONTIERS IN MEDICINE, 2022, 9
  • [37] A single-center analysis of visual outcomes and associated factors after intravenous methylprednisolone treatment for dysthyroid optic neuropathy
    Kemchoknatee, Parinee
    Tangon, Duanghathai
    Srisombut, Thansit
    BMC OPHTHALMOLOGY, 2023, 23 (01)
  • [38] Acute Dysthyroid Optic Neuropathy Exacerbated by Orbital Radiotherapy
    Hersh, Dov
    Kinnar, Merchant
    ORBIT-AN INTERNATIONAL JOURNAL ON ORBITAL DISORDERS AND FACIAL RECONSTRUCTIVE SURGERY, 2014, 33 (05): : 385 - 387
  • [39] Management of patients with dysthyroid optic neuropathy treated with intravenous corticosteroids and/or orbital decompression surgery
    Sandra Rezar-Dreindl
    Andrea Papp
    Arnulf Baumann
    Thomas Neumayer
    Katharina Eibenberger
    Eva Stifter
    Ursula Schmidt-Erfurth
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2022, 260 : 3683 - 3691
  • [40] Optic nerve compression associated with visual cortex functional alteration in dysthyroid optic neuropathy: A combined orbital and brain imaging study
    Zhang, Haiyang
    Liu, Yuting
    Jiang, Mengda
    Xia, Duojin
    Peng, Yuhang
    Zhu, Ling
    Tao, Xiaofeng
    Wang, Jue
    Li, Jipeng
    Sun, Jing
    Li, Yinwei
    Song, Xuefei
    Zhou, Huifang
    Fan, Xianqun
    CNS NEUROSCIENCE & THERAPEUTICS, 2024, 30 (07)